The main hypothesis to be tested is that the use of a quality improvement programme will lead to measurable improvements in the management of care and use of evidence based treatments for patients presenting to hospital with non-ST elevation acute coronary syndromes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
3,500
Quality Improvement training programme
Composite of 7 outcome measures to assess aggregate potential for improvement in care using the QI programme:1:risk stratification within 24 hrs, 2:early coronary angiography, 3:anticoagulation, 4:beta-blockers, 5:statins, 6:ACE-inhibitors, 7:Clopidogrel
Time frame: 10 months
Clinical outcomes at discharge including death and myocardial infarction
Time frame: 10 months
Estimated costs of care for patients
Time frame: 10 months
Estimated costs and economic evaluation of potential cost-effectiveness of QI programme
Time frame: 10 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Centre Hospitalier de la region d'Annecy
Annecy, France
RECRUITINGCentre Hospitalier de Chambery
Chambéry, France
RECRUITINGCardiology dept. B, CHU Hopital G. Montpied
Clermont-Ferrand, France
RECRUITINGCHU de Grenoble
Grenoble, France
RECRUITINGCentre Hospitalier de Riom Guy Thomas
Riom, France
RECRUITINGHopitaux Drome Nord de Romans-sur-Isere
Romans-sur-Isère, France
RECRUITINGCentre Hospitalier d'Ussel
Ussel, France
RECRUITINGCentre Hospitalier Pierre Bazin
Voiron, France
RECRUITINGOspedale M. Bufalini
Cesena, Italy
RECRUITINGOspedale Morgagni-Pierantoni
Forlì, Italy
RECRUITING...and 27 more locations